National Bank of Canada’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,430
Closed -$1.28M 2919
2023
Q2
$1.28M Hold
30,430
﹤0.01% 1084
2023
Q1
$1.08M Sell
30,430
-44,100
-59% -$1.6M ﹤0.01% 1029
2022
Q4
$2.73M Buy
74,530
+73,738
+9,310% +$2.91M 0.01% 795
2022
Q3
$37K Sell
792
-6,866
-90% -$443K ﹤0.01% 1808
2022
Q2
$548K Buy
7,658
+34
+0.4% +$2.49K ﹤0.01% 1185
2022
Q1
$620K Buy
7,624
+6,896
+947% +$583K ﹤0.01% 1259
2021
Q4
$75K Buy
+728
New +$69.9K ﹤0.01% 1726

Other funds holding SYNH

National Bank of Canada's SYNH Position: Q3 2023 in Review

National Bank of Canada sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 30,430 shares — an estimated $1.28M sold.

National Bank of Canada first reported a position in SYNH in Q4 2021 and held it in 7 quarters. The position peaked at $2.73M in Q4 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • National Bank of Canada reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • National Bank of Canada sold 30,430 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.28M.
  • National Bank of Canada first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • National Bank of Canada's Syneos Health, Inc. Class A Common Stock position peaked at $2.73M in Q4 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.